BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20511672)

  • 21. Morphological changes of poly(DI-lactide-co-glycolide) nano-particles containing ascorbic acid during in vitro degradation process.
    Stevanović M; Jordović B; Uskoković D
    J Microsc; 2008 Dec; 232(3):511-6. PubMed ID: 19094031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
    Jin C; Bai L; Wu H; Tian F; Guo G
    Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY; Feng SS
    Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
    Khdair A; Gerard B; Handa H; Mao G; Shekhar MP; Panyam J
    Mol Pharm; 2008; 5(5):795-807. PubMed ID: 18646775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
    Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
    Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery.
    Yi F; Wu H; Jia GL
    J Clin Pharm Ther; 2006 Feb; 31(1):43-8. PubMed ID: 16476119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone acetate encapsulation into Trojan particles.
    Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
    J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens.
    Beck-Broichsitter M; Thieme M; Nguyen J; Schmehl T; Gessler T; Seeger W; Agarwal S; Greiner A; Kissel T
    Macromol Biosci; 2010 Dec; 10(12):1527-35. PubMed ID: 20824691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
    Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
    Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D
    Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW; Wang SS; Tsai WJ
    Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
    Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
    Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.
    Acharya S; Dilnawaz F; Sahoo SK
    Biomaterials; 2009 Oct; 30(29):5737-50. PubMed ID: 19631377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein.
    Cai C; Bakowsky U; Rytting E; Schaper AK; Kissel T
    Eur J Pharm Biopharm; 2008 May; 69(1):31-42. PubMed ID: 18023160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.